Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Model for Metabolic Dysfunction-associated Steatotic Liver Disease Related Cirrhosis

NCT07082751 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT07082751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07082751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Model for Metabolic Dysfunction-associated Steatotic Liver Disease Related Cirrhosis
Lead sponsor
Beijing Friendship Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
August 13, 2025
Completion date
June 30, 2030
Enrollment
228 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

compensated cirrhosis, metabolic dysfunction associated steatotic liver disease